Drug Shortage Report for AURO-VALSARTAN HCT
| Report ID | 235918 |
| Drug Identification Number | 02408120 |
| Brand name | AURO-VALSARTAN HCT |
| Common or Proper name | AURO-VALSARTAN HCT |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE VALSARTAN |
| Strength(s) | 12.5MG 160MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100's |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-12-05 |
| Estimated end date | 2025-05-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-05-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-12-03 | English | Compare |
| v2 | 2024-08-26 | French | Compare |
| v1 | 2024-08-26 | English | Compare |